J&J funds Francis Medical to seek cancer indication for Vanquish device
Medical Device Network · 8h ago
Johnson & Johnson
Medicine & Biotech · covered by 13 outlets this week · tracked since 2026-10-27
Press: 3 mainstream 16 specialist 5 independent outlet-days
Background
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. Wikipedia ↗
Written by the Alivewire editors from the coverage below, 19h ago. Not medical advice; how the ratings work.
Coverage
STAT+: Why this former ER doc thinks giving AI less information is sometimes better
STAT Health Tech · 10h ago
study
Bispecific J&J Drug Wins Speedy FDA Approval for Treating Head & Neck Cancer
MedCity News · 5d ago
FDA approves Rybrevant Faspro for metastatic head, neck cancer
Healio · 5d ago
Johnson and Johnson Rybrevant Faspro Gets USFDA Accelerated Approval for Advanced Head, Neck Cancer
Medical Dialogues · 5d ago
J&J's Rybrevant Faspro moves beyond lung cancer with FDA nod
Pharmaphorum · 5d ago
At ASH, drugmakers to showcase early data for three-pronged cancer therapies
BioPharma Dive · 6d ago
estranslation pending
J&J trae a España un nuevo tratamiento para la miastenia gravis: "Los pacientes necesitan poder hacer planes"
Redacción Médica · 6d ago
study
GI Innovation doses 1st patient in prostate cancer trial with J&J's pasritamig
Korea Biomedical Review · 6d ago
ittranslation pending
Johnson & Johnson, 50 anni in Italia: investire in salute conviene, lo studio Cerm ne misura il valore
Quotidiano Sanità · 7d ago
ittranslation pending
Johnson & Johnson, primi 50 anni in Italia. L’Ad Murzi: «Consentiteci di investire ancora»
Il Sole 24 Ore Salute · 8d ago
On the benefits of earlier oncological intervention, with Johnson & Johnson
Pharmaphorum · 9d ago
UK approves J&J's oral psoriasis pill
The Hindu Health · 15d ago
Another autoimmune CAR-T death; Treasury zeroes in on China deals
BioPharma Dive · 16d ago
study
Gilead to Pay $1.3B for Oral Peptide That Could Rival J&J’s New Immunology Pill
MedCity News · 19d ago
Johnson & Johnson launches new coronary IVL catheter that cuts treatment times in half
Cardiovascular Business · 22d ago
podcast
After FDA Authorization, J&J’s Robotic Surgery President Looks Ahead to OTTAVA’s Commercial Rollout
DeviceTalks · 26d ago
estranslation pending
«Existe un contraste brutal entre la reputación de Johnson & Johnson y su comportamiento real»
ABC Salud · 31d ago
studypeer-reviewed
Allaying “Anxieties in Government Officials, Physicians and the Public”: Johnson & Johnson and The Lancet Editorial of 1977
AJPH · 41d ago
studypeer-reviewed
Allaying “Anxieties in Government Officials, Physicians and the Public”: Johnson & Johnson and The Lancet Editorial of 1977
AJPH · 41d ago
A Case of Misdirected Immunity
Virology Blog · 216d ago
study
Johnson & Johnson Endows Whitehead Institute Professorship in Memory of Susan Lindquist, Accomplished Researcher and Role Model for Women in Science
Whitehead Institute News · 3647d ago